IDEAYA Biosciences (IDYA) provided a business update including an overview of key corporate objectives for 2026. 2026 Corporate Objectives: Daro…
IDEAYA Biosciences (IDYA) provided a business update including an overview of key corporate objectives for 2026. 2026 Corporate Objectives: Darovasertib in uveal melanoma – Topline results, including progression free survival data, from ongoing regis… [1083 chars]
Source: Markets Insider | Published: 2026-01-11T19:45:23Z
Credit: Markets Insider
